These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 7971632)

  • 21. Pure red-cell aplasia with fludarabine for chronic lymphocytic leukaemia.
    Leporrier M; Reman O; Troussard X
    Lancet; 1993 Aug; 342(8870):555. PubMed ID: 8102691
    [No Abstract]   [Full Text] [Related]  

  • 22. Lysis pneumonopathy associated with the use of fludarabine phosphate.
    Crowley JJ; Knight L; Charan N
    West J Med; 1994 Dec; 161(6):597-9. PubMed ID: 7531920
    [No Abstract]   [Full Text] [Related]  

  • 23. Tumour debulking and reduction in predicted risk of tumour lysis syndrome with single-agent ibrutinib in patients with chronic lymphocytic leukaemia.
    Wierda WG; Byrd JC; O'Brien S; Coutre S; Barr PM; Furman RR; Kipps TJ; Burger JA; Stevens DA; Sharman J; Ghia P; Flinn IW; Zhou C; Ninomoto J; James DF; Tam CS
    Br J Haematol; 2019 Jul; 186(1):184-188. PubMed ID: 30740654
    [No Abstract]   [Full Text] [Related]  

  • 24. Cerebral toxoplasmosis in a patient with chronic lymphocytic leukaemia treated with fludarabine.
    Bacchu S; Fegan C; Neal J
    Br J Haematol; 2007 Nov; 139(3):349. PubMed ID: 17784883
    [No Abstract]   [Full Text] [Related]  

  • 25. [Whipple's disease as a complication of chronic lymphocytic leukemia treated with fludarabine].
    Kuliszkiewicz-Janus M; Małecki R; Kuliczkowski K; Jeleń M
    Pol Arch Med Wewn; 2002 Sep; 108(3):887-91. PubMed ID: 12600186
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fludarabine induced immune thrombocytopenia in a patient with CD5 positive B cell chronic lymphocytic leukemia.
    Usman M; Adil SN; Sajid R; Khurshid M
    J Pak Med Assoc; 2003 Oct; 53(10):496-7. PubMed ID: 14696895
    [No Abstract]   [Full Text] [Related]  

  • 27. Fludarabine, as well as 2-chlorodeoxyadenosine, can induce eosinophilia during treatment of lymphoid malignancies.
    Lärfars G; Udén-Blohmé AM; Samuelsson J
    Br J Haematol; 1996 Sep; 94(4):709-12. PubMed ID: 8826898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Eosinophilia during fludarabine treatment of chronic lymphocytic leukemia.
    Sezer O; Schmid P; Hallek M; Schweigert M; Beinert T; Langelotz C; Mergenthaler HG; Possinger K
    Ann Hematol; 1999 Oct; 78(10):475-7. PubMed ID: 10550560
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transfusion-associated graft-versus-host disease in fludarabine-treated B-chronic lymphocytic leukaemia.
    Maung ZT; Wood AC; Jackson GH; Turner GE; Appleton AL; Hamilton PJ
    Br J Haematol; 1994 Nov; 88(3):649-52. PubMed ID: 7819085
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cryptococcal meningitis following fludarabine treatment for chronic lymphocytic leukemia.
    Leenders A; Sonneveld P; de Marie S
    Eur J Clin Microbiol Infect Dis; 1995 Sep; 14(9):826-8. PubMed ID: 8536738
    [No Abstract]   [Full Text] [Related]  

  • 31. Severe respiratory syncytial virus pneumonia complicating fludarabine and cyclophosphamide treatment of chronic lymphocytic leukemia.
    Field K; Slavin MA; Seymour JF
    Eur J Haematol; 2002 Jul; 69(1):54-7. PubMed ID: 12270063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor lysis syndrome complicating treatment of chronic lymphocytic leukemia with fludarabine phosphate.
    List AF; Kummet TD; Adams JD; Chun HG
    Am J Med; 1990 Sep; 89(3):388-90. PubMed ID: 1697447
    [No Abstract]   [Full Text] [Related]  

  • 33. Severe autoimmune hemolytic anemia in a patient with chronic lymphocytic leukemia responsive to fludarabine-based treatment.
    Tosti S; Caruso R; D'Adamo F; Picardi A; Ali Ege M; Girelli G; Mauro FR; Maurillo L; Amadori S
    Ann Hematol; 1992 Nov; 65(5):238-9. PubMed ID: 1457584
    [No Abstract]   [Full Text] [Related]  

  • 34. Evans syndrome complicating fludarabine treatment for advanced B-CLL.
    Shvidel L; Shtarlid M; Klepfish A; Sigler E; Berrebi A
    Br J Haematol; 1997 Dec; 99(3):706. PubMed ID: 9401088
    [No Abstract]   [Full Text] [Related]  

  • 35. Fludarabine for chronic lymphocytic leukemia.
    Copur MS; Ledakis P; Muhvic J
    N Engl J Med; 2001 Apr; 344(15):1166; author reply 1167-8. PubMed ID: 11302141
    [No Abstract]   [Full Text] [Related]  

  • 36. Acute renal failure as a consequence of urine stop flow in a patient with chronic lymphocytic leukemia after treatment with fludarabine.
    Montillo M; Tedeschi A; Leoni P
    Am J Hematol; 1995 Sep; 50(1):73-4. PubMed ID: 7668241
    [No Abstract]   [Full Text] [Related]  

  • 37. Severe autoimmune hemolytic anemia in two patients treated with fludarabine for chronic lymphocytic leukemia.
    Bastion Y; Coiffier B; Dumontet C; Espinouse D; Bryon PA
    Ann Oncol; 1992 Feb; 3(2):171-2. PubMed ID: 1606091
    [No Abstract]   [Full Text] [Related]  

  • 38. Severe autoimmune hemolytic anemia following fludarabine therapy in a patient with chronic lymphocytic leukemia.
    Tsiara S; Christou L; Konstantinidou P; Panteli A; Briasoulis E; Bourantas KL
    Am J Hematol; 1997 Apr; 54(4):342. PubMed ID: 9092698
    [No Abstract]   [Full Text] [Related]  

  • 39. Fatal fludarabine-induced extensive bone marrow necrosis in a patient with chronic lymphocytic leukemia.
    Braester A; Elmalah Y; Quitt M
    Leuk Lymphoma; 2003 Oct; 44(10):1835-6. PubMed ID: 14692545
    [No Abstract]   [Full Text] [Related]  

  • 40. Fludarabine.
    Med Lett Drugs Ther; 1991 Sep; 33(853):89-90. PubMed ID: 1886506
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.